What is CASI Pharmaceuticals Inc (CASI) stock price today?

CASI Pharmaceuticals Inc (CASI) currently trades at $0.21 per share. The stock has a market capitalization of $3.21M and a P/E ratio of —x.

Is CASI stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, CASI Pharmaceuticals Inc has a Smart Value Score of 24/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is CASI Pharmaceuticals Inc's revenue and earnings?

CASI Pharmaceuticals Inc has trailing twelve-month (TTM) revenue of $26.85M with profit margins of -184.00%. Earnings per share (EPS) is $-3.02.

CASI

CASI Pharmaceuticals Inc

NASDAQ: CASI · HEALTHCARE · BIOTECHNOLOGY

$0.21

+0.00% today

Updated 2026-04-29

Market cap

$3.21M

P/E ratio

—

P/S ratio

0.12x

EPS (TTM)

$-3.02

Dividend yield

—

52W range

$0 – $3

Volume

1.0M

Market cap

$3.21M

P/E ratio

—

P/S ratio

0.12x

EPS (TTM)

$-3.02

Dividend yield

—

52W range

$0 – $3

Volume

1.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$4.00

+1827.71%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at -184.00%

- Revenue declining -60.50% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$30.17M	$43.11M	$33.88M	$28.54M	$26.85M
Net income	$-36.65M	$-41.01M	$-26.94M	$-39.26M	$-10.88M
EPS	—	—	—	—	$-3.02
Free cash flow	$-42.34M	$-26.70M	$-22.21M	$-29.46M	—
Profit margin	-121.50%	-95.14%	-79.51%	-137.57%	-184.00%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CASI	$3.21M	24	2.7	2.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

CASI Pharmaceuticals Inc trades at $0.21. Our Smart Value Score of 24/100 indicates the stock is weak. TTM revenue stands at $26.85M. with profit margins at -184.00%.

Frequently asked questions

What is CASI Pharmaceuticals Inc's stock price?

CASI Pharmaceuticals Inc (CASI) trades at $0.21.

Is CASI Pharmaceuticals Inc overvalued?

Smart Value Score 24/100 (Grade F, Strong Sell).

What is the price target of CASI Pharmaceuticals Inc (CASI)?

The analyst target price is $4.00, representing +1827.7% upside from the current price of $0.21.

What is CASI Pharmaceuticals Inc's revenue?

TTM revenue is $26.85M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryChina

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.12x

ROE-1,095.00%

Beta0.89

50D MA$0.83

200D MA$1.38

Shares out0.02B

Float0.01B

Short ratio—

Avg volume1.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CASI vs LLY →CASI vs JNJ →CASI vs ABBV →Stock screener →